Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Drug repurposing shows promise for treating many medical conditions.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

These new skin treatments are safer and more effective with minimal side effects.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Compound 7p shows strong potential as an anticancer agent.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

A specific mutation known for causing cancer is also found to cause a skin condition in a young girl.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

BMS-470539 reduces skin fibrosis and inflammation.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Baricitinib was effective in treating both early and late onset alopecia areata.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.